Predictors of prolonged hospitalization and perioperative complications following mid-urethral sling mesh removal.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 14 12 2021
accepted: 19 04 2022
pubmed: 10 5 2022
medline: 30 6 2022
entrez: 9 5 2022
Statut: ppublish

Résumé

To assess preoperative and perioperative characteristics associated with increased length of stay and major complications after mid-urethral sling mesh removal. We performed an IRB-approved retrospective analysis of patients who underwent mid-urethral sling mesh removal. Demographic data and baseline surgical characteristics were collected. Operative reports and hospital/clinic notes were reviewed for complications which were categorized using the Clavien-Dindo Classification scheme. Length of stay was deemed abnormal if greater than 1 day. Complications were assessed using multivariate regression analysis. A total of 468 patients were identified as having undergone mid-urethral sling mesh removal. Mean age was 56 (± 11.1). 431 patients had either retropubic or transobturator slings. 241 patients underwent retropubic or groin exploration as a part of their mesh removal. A prolonged length of stay was noted in 73 patients (15.6%) and 13 patients (2.8%) experienced a Clavien Grade 3 complication. Pre-operative narcotic/benzodiazepine use, concomitant surgical procedure, bladder injury, increased ASA class, and major complications had an increased odds of a prolonged length of stay. Patients who experienced a bladder injury, groin/suprapubic incision, and estimated blood loss of over 400 mL had an increased odds of Clavien Grade 3 complications. Patient characteristics and perioperative factors are associated with increased length of stay and major complications after mid-urethral sling mesh removal.

Identifiants

pubmed: 35534576
doi: 10.1007/s00345-022-04021-3
pii: 10.1007/s00345-022-04021-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1793-1797

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Ulmsten U, Henriksson L, Johnson P et al (1996) An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 7(2):81–86. https://doi.org/10.1007/bf01902378
doi: 10.1007/bf01902378 pubmed: 8798092
American Urogynecologic Society/Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction (2014) Mesh Midurethral for Stress Urinary Incontinence
Ford AA, Rogerson L, Cody JD et al (2017) Mid-urethral sling operations for stress urinary incontinence in women. Cochrane DB Syst Rev. https://doi.org/10.1002/14651858.cd006375.pub4
doi: 10.1002/14651858.cd006375.pub4
Blaivas JG, Purohit RS, Benedon MS et al (2015) Safety considerations for synthetic sling surgery. Nat Rev Urol 12(9):481–509
doi: 10.1038/nrurol.2015.183
Rogo-Gupta L, Grisales T, Huynh L et al (2015) Symptom improvement after prolapse and incontinence graft removal in a case series of 306 patients. Female Pelvic Med Reconstr Surg 21(6):319–324. https://doi.org/10.1097/spv.0000000000000191
doi: 10.1097/spv.0000000000000191 pubmed: 26506159
Ramart P, Ackerman AL, Cohen SA et al (2017) The risk of recurrent urinary incontinence requiring surgery after suburethral sling removal for mesh complications. Urology 106:203–209. https://doi.org/10.1016/j.urology.2017.01.060
doi: 10.1016/j.urology.2017.01.060 pubmed: 28476681
King AB, Tenggardjaja C, Goldman HB (2016) Prospective evaluation of the effect of thigh dissection for removal of transobturator mid urethral slings on refractory thigh pain. J Urol 196(4):1207–1212. https://doi.org/10.1016/j.juro.2016.03.153
doi: 10.1016/j.juro.2016.03.153 pubmed: 27049875
Miklos JR, Chinthakanan O, Moore RD et al (2016) Indications and complications associated with the removal of 506 pieces of vaginal mesh used in pelvic floor reconstruction: a multicenter study. Surg Technol Int 26:185–189
Chinthakanan O, Miklos JR, Moore RD et al (2016) The indication and surgical treatment of 286 midurethral synthetic sling complications: a multicenter study. Surg Technol Int 29:167–171
pubmed: 27780346
Pickett SD, Barenberg B, Quiroz LH et al (2015) The significant morbidity of removing pelvic mesh from multiple vaginal compartments. Obstet Gynecol 125(6):1418–1422
doi: 10.1097/AOG.0000000000000870
Raz S (2015) Atlas of vaginal reconstructive surgery
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
doi: 10.1097/01.sla.0000133083.54934.ae pubmed: 15273542 pmcid: 1360123
English EM, Bell S, Kamdar NS et al (2019) Importance of estimated blood loss in resource utilization and complications of hysterectomy for benign indications. Obstet Gynecol 133(4):650–657. https://doi.org/10.1097/aog.0000000000003182
doi: 10.1097/aog.0000000000003182 pubmed: 30870284 pmcid: 6485959
Welk B, Al-Hothi H, Winick-Ng J (2015) Removal or revision of vaginal mesh used for the treatment of stress urinary incontinence. JAMA Surg 150(12):1167–1175. https://doi.org/10.1001/jamasurg.2015.2590
doi: 10.1001/jamasurg.2015.2590 pubmed: 26352538
Gurol-Urganci I, Geary RS, Mamza JB et al (2018) Long-term rate of mesh sling removal following Midurethral mesh sling insertion among women with stress urinary incontinence. JAMA 320(16):1659–1669. https://doi.org/10.1001/jama.2018.14997
doi: 10.1001/jama.2018.14997 pubmed: 30357298 pmcid: 6233805
Deng DY, Rutman M, Raz S et al (2007) Presentation and management of major complications of midurethral slings: are complications under-reported? Neurourol Urodyn 26(1):46–52. https://doi.org/10.1002/nau.20357
doi: 10.1002/nau.20357 pubmed: 17149713
Lee D, Bacsu C, Zimmern PE (2015) Meshology: a fast-growing field involving mesh and/or tape removal procedures and their outcomes. Expert Rev Med Devices 12(2):201–216. https://doi.org/10.1586/17434440.2015.985655
doi: 10.1586/17434440.2015.985655 pubmed: 25483725

Auteurs

Zaid Chaudhry (Z)

AltaMed Health Services, El Monte, CA, USA. ZaidQChaudhry@gmail.com.

Evgeniy Kreydin (E)

Catherine and Joseph Aresty Department of Urology, Keck School of Medicine of USC, Los Angeles, CA, USA.

Janine Oliver (J)

Division of Urology, Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA.

Shlomo Raz (S)

Division of Pelvic Medicine and Reconstructive Surgery, Department of Urology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH